ENTITY
Sun Pharma

Sun Pharma (SUNP IN)

353
Analysis
Health Care • India
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs). It offers a wide range of products across chronic and acute therapies, including generics, branded generics, and specialty products. The company was founded in 1983 and is headquartered in Mumbai, India.
more
bearish•Travel Food Services
•08 Jul 2025 09:55

Travel Food Services IPO - RHP Updates & Thoughts on Valuation

Travel Food Services (TFS) is looking to raise about US$233m in its India IPO. In this note, we will talk about the RHP updates and IPO valuations.

Logo
770 Views
Share
bearish•Mankind Pharma
•12 Dec 2023 08:34

Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release

The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...

Logo
934 Views
Share
bearish•Sun Pharma
•04 May 2026 08:30

Sun Pharmaceutical (SUNP IN): Organon Acquisition to Enhance Scale At the Cost of Growth

​Sun Pharma to acquire Organon for $14 per share in all-cash deal, boosting innovative medicines business revenue share to 27%, up from 20% now....

Logo
153 Views
Share
bullish•Sun Pharma
•28 Apr 2026 08:51•Broker

Sun Pharmaceutical Industries: Organon M&A Provides Scale, Growth Revival Key.

Sun Pharma has entered into a definitive agreement to acquire Organon & Co (Organon) in an all-cash transaction deal (all outstanding shares)

Logo
158 Views
Share
•28 Jun 2026 08:30

APAC Healthcare Weekly (June 28) – Insilico, Abbisko, Nippon Shinyaku, Otsuka, Yuhan Corp, Medytox

Few Chinese companies signed outlicensing deals. Nippon Shinyaku’s partner Regenxbio will resubmit gene therapy drug candidate to FDA. Otsuka...

Logo
144 Views
Share
x